TLR4 and crescentic glomerulonephritis: TLR2 promotes crescentic glomerulonephritis [48], whereas TLR4 promotes inflammation associated with ischemic AKI in diabetic mice, which can be rescued by the TLR4 specific inhibitor CRX-526 [49,50].